HARBINGERHX Trademark

Trademark Overview


On Wednesday, November 29, 2023, a trademark application was filed for HARBINGERHX with the United States Patent and Trademark Office. The USPTO has given the HARBINGERHX trademark a serial number of 98290220. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, December 20, 2024. This trademark is owned by Harbinger Health, Inc.. The HARBINGERHX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer; pharmaceutical preparations comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; drug discovery platform services

General Information


Serial Number98290220
Word MarkHARBINGERHX
Filing DateWednesday, November 29, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, December 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer; pharmaceutical preparations comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; drug discovery platform services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 20, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHarbinger Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02138

Trademark Events


Event DateEvent Description
Thursday, November 30, 2023NEW APPLICATION ENTERED
Friday, February 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2024ASSIGNED TO EXAMINER
Friday, June 28, 2024NON-FINAL ACTION WRITTEN
Friday, June 28, 2024NON-FINAL ACTION E-MAILED
Friday, June 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 19, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, July 19, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, December 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED